Interventional technology developer Endologix has appointed John Zehren as its chief commercial officer (CCO), effective January 7.
Zehren has more than 20 years of commercial, sales and marketing, and business development experience in the medical device industry. His most recent post was as vice president of sales for the Americas at Medtronic Neurovascular. Before Medtronic, Zehren served as vice president of sales at Covidien and ev3 and vice president of sales and marketing at Edwards Lifesciences, Endologix said.
